Case report: ex vivo tumor organoid drug testing identifies therapeutic options for stage IV ovarian carcinomaMarwah Al-Aloosi, Carla Grandori, Christopher J. Kemp et al.|Frontiers in Oncology|2024Cited by 8
Abstract 3399: Tumor organoid based drug sensitivity testing in ovarian cancer identifies exceptional responders to targeted therapiesAmanda M. Prechtl, Carla Grandori, Marwah Al-Aloosi et al.|Cancer Research|2023Cited by 0